Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384254 · ClinicalTrials.gov registry record · Phase 2
Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention
A Phase 2 study of Tobacco Use Cessation, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,177
- Enrollment target
- 1
- Study location
NCT00384254: Completed Phase 2 study of Tobacco Use Cessation, sponsored by Oregon Research Institute.
NCT00384254 is a Phase 2 study of Tobacco Use Cessation that has completed, run by Oregon Research Institute. The registered enrollment target is 2,177 participants, above the 824-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (164% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00384254, a Phase 2 study of Tobacco Use Cessation, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare two methods for providing brief dental office-based interventions designed to help patients quit either cigarette smoking or smokeless tobacco use, and to compare these two dental office-based interventions with usual care. This trial will evaluate the effectiveness of a unique combination of dental office intervention plus referral to the telephone help line, both of which have been demonstrated to be effective interventions for tobacco cessation. The integration of two lines of research-dental office interventions and telephone help line effectiveness-led us to propose this clinical trial as a more efficient and disseminable model of both training and practice.
Conditions Studied
Interventions
- BEHAVIORAL 5 A
- BEHAVIORAL 3 A
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,177 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
What the finished NCT00384254 record still lists
NCT00384254 is an interventional study that assigns participants to a tested intervention. Its 2,177 participants enrollment target places it among the larger protocols in the corpus, above the 824-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (164% higher).
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 2 interventions - of which 5 A is the first listed.
NCT00384254 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT00384254 about?
NCT00384254 is a clinical study titled "Tobacco Quitlines:Adjunct to Dental Office Tobacco Intervention". The purpose of the study is to compare two methods for providing brief dental office-based interventions designed to help patients quit either cigarette smoking or smokeless tobacco use, and to compare these two dental office-based interventions with usual care. This trial will evaluate the effectiv...
What is the current status of trial NCT00384254?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,177 participants. The study started on 2004-01. Estimated completion is 2008-01.
What conditions does trial NCT00384254 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT00384254?
The interventions under investigation include: 5 A (BEHAVIORAL), 3 A (BEHAVIORAL).
Who is sponsoring clinical trial NCT00384254?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00384254 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00384254's enrollment target sits among peer trials
2,177 5th of 36 higher than 32 of 36 other Tobacco Use Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
COMPLETED · Phase 2
-
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
COMPLETED · Phase 2
-
Cannabis-Tobacco Co-Use Treatment Study
RECRUITING · Phase 3
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia